These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 22221778

  • 41. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
    Colombo AA, Rusconi C, Esposito C, Bernasconi P, Caldera D, Lazzarino M, Alessandrino EP.
    Transplantation; 2006 Apr 27; 81(8):1087-92. PubMed ID: 16641591
    [Abstract] [Full Text] [Related]

  • 42. Hematopoietic stem cell transplantation and the 'eye of the tiger'.
    Cooper DL.
    J Support Oncol; 2010 Apr 27; 8(3):117-8. PubMed ID: 20552924
    [No Abstract] [Full Text] [Related]

  • 43. [Long-term follow-up of patients undergoing allogeneic hematopoietic stem cell transplantation in Japan].
    Hagiwara S, Mochizuki T, Kondo M, Mori A, Fukuda T.
    Rinsho Ketsueki; 2010 Mar 27; 51(3):167-73. PubMed ID: 20379110
    [Abstract] [Full Text] [Related]

  • 44. Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.
    Trenado A, Fisson S, Braunberger E, Klatzmann D, Salomon BL, Cohen JL.
    Transplantation; 2004 Jan 15; 77(1 Suppl):S32-4. PubMed ID: 14726768
    [Abstract] [Full Text] [Related]

  • 45. Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations.
    Shallis RM, Gleeson S, Azar MM, Malinis M, Xu ML, Seropian SE, Gowda L, Zeidan AM.
    Leuk Lymphoma; 2019 Oct 15; 60(10):2584-2587. PubMed ID: 30943051
    [No Abstract] [Full Text] [Related]

  • 46. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.
    Hingorani S.
    J Am Soc Nephrol; 2006 Jul 15; 17(7):1995-2005. PubMed ID: 16723390
    [Abstract] [Full Text] [Related]

  • 47. Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?
    Snowden JA, Nivison-Smith I, Atkinson K, Fay K, Concannon A, Dodds A, Milliken S, Biggs J.
    Bone Marrow Transplant; 2000 Jan 15; 25(1):119-20. PubMed ID: 10654027
    [No Abstract] [Full Text] [Related]

  • 48. Graft engineering.
    Noga SJ.
    Semin Oncol; 2000 Apr 15; 27(2 Suppl 5):15-21. PubMed ID: 10877046
    [Abstract] [Full Text] [Related]

  • 49. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G.
    Biol Blood Marrow Transplant; 2007 Nov 15; 13(11):1304-12. PubMed ID: 17950917
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes.
    Uberti JP, Ayash L, Braun T, Reynolds C, Silver S, Ratanatharathorn V.
    Bone Marrow Transplant; 2004 Sep 15; 34(5):425-31. PubMed ID: 15273705
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.
    Hewamana S, Austen B, Murray J, Johnson S, Wilson K.
    Eur J Haematol; 2009 Sep 15; 83(3):277. PubMed ID: 19467016
    [No Abstract] [Full Text] [Related]

  • 54. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E, Koza V, Vítek A, Mayer J, Sedlácek P, Zák P, Zapletalová J, Benesová K, Krejcová H, Steinerová K, Maresová I, Cetkovský P.
    Vnitr Lek; 2006 Dec 15; 52(12):1172-80. PubMed ID: 17299910
    [Abstract] [Full Text] [Related]

  • 55. Endocrine complications in long-term survivors after allogeneic stem cell transplant.
    Gunasekaran U, Agarwal N, Jagasia MH, Jagasia SM.
    Semin Hematol; 2012 Jan 15; 49(1):66-72. PubMed ID: 22221786
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors.
    Dignan FL, Manwani R, Potter MN, Ethell ME, Leonard H, Brennan J, Baker J, Shaw BE.
    Clin Transplant; 2013 Jan 15; 27(1):E1-2. PubMed ID: 23215823
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Chronic graft-vs-host disease.
    Bhushan V, Collins RH.
    JAMA; 2003 Nov 19; 290(19):2599-603. PubMed ID: 14625337
    [No Abstract] [Full Text] [Related]

  • 60. Long-term control of extensive refractory chronic graft versus host disease in a multiple myeloma relapsing after allogeneic transplant. A case report.
    Cocito F, Mangiacavalli S, Bernasconi P, Colombo AA, Caldera D, Cartia CS, Ganzetti M, Troletti D, Cazzola M, Corso A.
    Leuk Lymphoma; 2017 Nov 19; 58(11):2770-2771. PubMed ID: 28287281
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.